Pharmafile Logo
Pharmafocus logo
Advanced Search

Sanofi

Showing 15 posts of 579 posts found.

Sanofi – aiming for number one in the world’s biggest diabetes market

December 18, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, Sanofi, diabetes, obesity

Sanofi is no different from any other major pharma company in seeing China as the single most important growth market …

Feature
genzyme image

CHMP turns down Kynamro

December 17, 2012
Sales and Marketing CHMP, Genzyme, Kynamro, Sanofi

Genzyme has expressed frustration at the CHMP’s negative opinion of its novel drug Kynamro, and plans to ask it to …

News
Sanofi image

Working Life: Caroline Horwood

December 6, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Working Life

How did you find your way into your current role?Through an exciting and challenging route over 25 years! The key …

Feature

Pharmacos ink green manufacturing pact with EU academics

December 3, 2012
Manufacturing and Production Bayer, EU, Pharmacos, Sanofi

A group of top pharma multinationals have set up a public-private partnership dedicated to the development of manufacturing sustainable pharmaceuticals …

News

European nod for Sanofi drugs

November 19, 2012
Research and Development, Sales and Marketing CHMP, Sanofi

Two of Sanofi’s key drugs have cleared the penultimate hurdle to approval in Europe with a recommendation from the CHMP. …

News

Sanofi appoints Gary Nabel as chief scientific officer

November 16, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nabel, Sanofi

Sanofi has announced the appointment of Dr Gary Nabel, senior VP, chief scientific officer and deputy to the president for …

Appointment

Regeneron to invest $70m in NYC manufacturing

November 15, 2012
Manufacturing and Production NY, Regeneron, Sanofi, US

Regeneron has confirmed it will invest almost $70 million to expand its manufacturing in New York City in a move …

News
screen_shot_2012-11-07_at_10

Sanofi’s chief executive new president elect of EFPIA

November 7, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Viehbacher, Sanofi

European pharma members body the EFPIA has announced that Sanofi’s chief executive Christopher Viehbacher is to stand as its new …

Appointment

Sanofi criticised for multiple sclerosis manoeuvres

November 2, 2012
Sales and Marketing Cancer, Lemtrada, MS, Sanofi

Sanofi is facing a backlash as it prepares its new MS treatment for the market. Lemtrada (alemtuzumab) has produced very …

News
sanofi image

Diabetes softens generics blow for Sanofi

October 30, 2012
Sales and Marketing Eloxatin, Plavix, Sanofi, diabetes, emerging markets, patent cliff

Sanofi has unveiled its results for the third quarter, with news that the damage done by patent expiries has not …

News
genzyme image

FDA committee recommends Kynamro

October 23, 2012
Research and Development, Sales and Marketing FDA, Genzyme, Kynamro, Sanofi

Sanofi’s anti-cholestrol drug Kynamro has been recommended by an FDA committee, paving the way for US approval early next year. …

News
Zaltrap image

Sanofi’s Zaltrap data published

October 8, 2012
Research and Development, Sales and Marketing Erbitux, Sanofi, Stivarga, Zaltrap, avastin

Detailed data from the Phase III trial of Sanofi’s newly-licenced anti-VEGF cancer drug Zaltrap, co-marketed with Regeneron, has been published. …

News

Sanofi acquires leading Colombian firm

October 4, 2012
Sales and Marketing Columbia, Genfar, Latin America, Sanofi

Sanofi is expanding its presence in Latin American with the acquisition of a Colombian pharma company. Genfar is headquartered in …

News
BMS image

Patent losses force change for Sanofi

October 3, 2012
Sales and Marketing Avapro, BMS, Plavix, Sanofi, patent loss

Patent expiries are behind the decision by Sanofi and Bristol-Myers Squibb to radically restructure their long-term corporate alliance. The loss …

News

Quality issues prompt Sanofi typhoid vaccine recall

October 3, 2012
Manufacturing and Production Sanofi, Typhen Vi, recall

Sanofi has recalled several lots of its typhoid fever vaccine Typhim Vi on fears that a quality defect could compromise …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025